$IRWD News

Ironwood Pharmaceuticals Appoints Tammi Gaskins as Chief Executive Officer

Ironwood Pharmaceuticals Appoints Tammi Gaskins CEO, Effective Jan. 1, 2027

Will Linzess Continue to Aid Ironwood's Top-Line Growth in Q3?

Ironwood Pharmaceuticals: The Stock Is A Call On The Second Apraglutide Trial - Buy

Ironwood Pharmaceuticals Reports Q2 2026 Results: Full Earnings Call Transcript

Ironwood: Medicare Is Not The Problem I Thought It Was

Ironwood Pharmaceuticals to Participate in the Wells Fargo 21st Annual Healthcare Conference

Ironwood Pharmaceuticals: High Dependence On Its Next Trial

Ironwood Pharmaceuticals (NASDAQ:IRWD) Highlights Minervini Trend Template and High Growth Momentum

Ironwood (IRWD) Q2 2026 Earnings Call Transcript

Ironwood Pharmaceuticals, Inc. Q2 2026 Earnings Call Summary

Ironwood Pharmaceuticals (IRWD) Is Up 14.2% After Raising 2026 Revenue Guidance – Has The Bull Case Changed?

Ironwood Pharmaceuticals Inc (IRWD) (Q2 2026) Earnings Call Highlights: Strong LINZESS Growth ...

Ironwood Pharmaceuticals Q2 Earnings Call Highlights

Ironwood Pharmaceuticals, Inc. (IRWD) Q2 2026 Earnings Call Transcript

Ironwood Pharmaceuticals, Inc. 2026 Q2 - Results - Earnings Call Presentation

Ironwood Pharmaceuticals (IRWD) Q2 Earnings Top Estimates

Ironwood Pharmaceuticals (NASDAQ:IRWD) Raises Full-Year Guidance on Strong LINZESS Sales Despite Q2 Miss

Ironwood Pharmaceuticals Raises 2026 Full-Year Financial Guidance Building on Strong Second Quarter Results

Ironwood Pharmaceuticals Raises FY2026 Sales Guidance from $450.000M-$475.000M to $460.000M-$485.000M vs $460.118M Est